Sequoia Capital
Ant Financial leads Series C for Chinese logistics player Keking
Chinese logistics cloud-based software provider Keking has raised RMB1 billion ($143.7 million) in a Series C round of funding led by Ant Financial and Centurium Capital.
China's WuXi NextCode closes $200m Series C
WuXi NextCode, a genome sequencing analysis business with ties to China-based contract research organization WuXi PharmaTech, has raised $200 million in a Series C round of funding from a consortium led by the Ireland Strategic Investment Fund (ISIF).
Chinese AI player Aibee gets $60m Series A
China and US-based artificial intelligence (AI) solutions provider Aibee has raised $60 million in a Series A round of funding led by Sequoia Capital China and Red Star Macalline, a Hong Kong-listed furniture mall operator.
Chinese electric car maker LeapMotor raises $288m
Hangzhou-based electric car maker LeapMotor has raised RMB2 billion ($288 million) in a Series A round of funding led by Shanghai Electric - a Hong Kong-listed Chinese power generation and electrical equipment manufacturer.
PE-backed Chinese fashion platform Mogujie files for US IPO
Chinese online shopping and social networking business Mogujie has filed to list in the US. The company's investors include Tencent Holdings, Trustbridge Partners, and Hillhouse Capital.
PE-backed CStone files for Hong Kong IPO
CStone Pharmaceuticals, a cancer-focused Chinese biopharmaceutical developer with a number of PE and VC backers, has filed for an IPO in Hong Kong.
Sequoia China, ZhenFund launch entrepreneur club
Sequoia China Capital and ZhenFund have announced plans to launch a non-profit community dedicated to providing training courses and resources to Chinese entrepreneurs.
China's Linear Venture closes third fund
China’s Linear Venture has closed its third fund with a renminbi-denominated vehicle of RMB500 million ($72 million) and a US dollar-denominated vehicle of $70 million.
India's Meesho raises $50m Series C
Meesho, an Indian e-commerce platform focused on small businesses and emerging brands, has raised a $50 million Series C round led by Shunwei Capital, RPS Ventures, and DST Partners.
Deal focus: XtalPi takes big pharma into the cloud
China and US-based XtalPi has raised $61 million this year from investors impressed its use of quantum physics, computational chemistry, and artificial intelligence to bring greater certainty to drug development
Innovent Biologics gains on debut after $421m IPO
Chinese cancer drug developer Innovent Biologics, which has a number of PE backers, closed up on its Hong Kong trading debut, following a HK$3.3 billion ($421 million) IPO.
Insight hits $72m second close on China healthcare fund
China’s Insight Capital has reached a second close on its latest healthcare fund with commitments of RMB500 million ($71.7 million).
SE Asia-focused Chinese fintech player gets $70m Series C
Akulaku, a Chinese consumer finance platform that primarily serves customers in Southeast Asia, has raised $70 million in a Series C round led by fintech company Finup Group. Sequoia Capital India, Blue Sky Venture Capital, and Qiming Venture Partners...
China Life backs AI drug development platform XtalPi
A healthcare fund managed by China Life Insurance has led a $46 million extended Series B investment in XtalPi, a US-based artificial intelligence-enabled healthcare services platform established by Chinese scientists.
Chinese HR SaaS player Beisen gets $100m Series E
Beisen, a Chinese cloud-based software-as-a-service (SaaS) provider specializing in human resources, has raised over $100 million in a Series E round led by Matrix Partners and Genesis Capital, with participation from Sequoia China Capital. All three...
Warburg Pincus backs Indonesia tax compliance business
Warburg Pincus has led a $25 million Series B round of funding for OnlinePajak, an Indonesia-based company that operates an online tax reporting platform.
Sequoia India establishes separate VC, growth teams
Sequoia Capital India has split its investment staff, creating separate teams for India and Southeast Asia focused on venture and growth capital investments. The firm's China and US affiliates already employ a similar strategy.
Fresh China gets $43m Series B led by IDG
Fresh China, a domestic fresh food retailer also known as Shengxian Chuanqi, has raised RMB300 million ($43.3 million) in a Series B round led by IDG Capital with participation from Sequoia Capital and BA Capital.
Sequoia leads Series B for China's Deep Intelligent Pharma
Deep Intelligent Pharma (DIP) has raised $15 million in a Series B funding from Sequoia Capital China, with the proceeds to be used for accelerating the development of the company’s artificial intelligence (AI) powered drug discovery platform.
Sequoia leads $27m round for India's BlackBuck
Sequoia Capital India has led an approximately $27 million investment in Indian logistics services company BlackBuck.
Singapore's One Championship receives $166m Series D
Sequoia Capital has led a $166 million Series D funding round for One Championship, a Singapore-based mixed martial arts (MMA) organization that stages tournaments across the region.
Deal focus: Oyo passes the $1b mark
Oyo Rooms has taken a budget hotel marketing strategy that worked in India and applied it to overseas markets, notably China. Investors were bullish enough on its growth potential to provide a $1 billion Series E round
China Sports Capital leads $15m round for gaming network
Fighting Esports Group (FEG), a China-based online gaming network, has raised a RMB100 million ($14.5 million) Series A round led by China Sports Capital, a joint venture between Sequoia Capital China and CMC Capital Partners.
China's Cootek struggles on trading debut, vows to push forward
CooTek – the VC-backed Chinese app developer behind the TouchPal smart phone keyboard – shrugged off a disappointing trading debut in New York and pledged to cultivate new products with a view to easing reliance on its flagship offering.